The Ideal Patient for Biomarker Testing in Anal Carcinoma
Cathy Eng, MD, FACP, FASCO, discusses the types of patients who should be tested for biomarkers in the anal cancer space.
The Role of Biomarker Testing in Anal Cancer
Cathy Eng, MD, FACO, FASCO, discusses how biomarkers are being explored to aid the treatment of anal cancers.
NTRK Fusion–Positive Colon Cancer: Final Thoughts
NTRK-Targeted Therapy in Colon Cancer: Dosing and Management
NTRK-Targeted Therapy for Patients With Colon Cancer
Treatment Options for NTRK Fusion–Positive mCRC
Testing for NTRK Fusion–Positive Metastatic Colon Cancer
Case-Based Overview: NTRK Fusion–Positive mCRC
A 68-Year-Old Woman with Metastatic NTRK Fusion-Positive Colon Cancer
Cathy Eng, MD, FACP, FASCO, reviews the case of a 68-year-old diagnosed with metastatic NTRK fusion-positive colon cancer and shares treatments options.